Artery Technology Corp

Artery Technology Corp maintains a strong liquidity position with $317.8 million in cash and equivalents, representing 26.3% of total assets. The company's liquidity FPT score of 8.33 indicates a high cash buffer relative to market cap, supported by a current ratio of 4.43 and no immediate liquidity flags in risk assessment. Profitability metrics show mixed performance. The company's ROE of 9.33% and ROA of 7.05% exceed the median for the semiconductor industry, but its gross margin of 29.6% (484.7 million gross profit on 1.635 billion revenue) lags behind top-tier competitors. Operating margin of 4.76% (77.8 million operating income) reflects moderate cost control in a capital-intensive industry. Geographic and segment exposure remains undisclosed in the latest financial filings, though the company's product portfolio spans consumer electronics and industrial applications. Revenue concentration data is not available in the current dataset, limiting assessment of diversification risk. Growth trajectory shows modest momentum with 1.635 billion in revenue, but forward-looking guidance is constrained by limited historical data. Capital expenditure of -4.37 million suggests minimal near-term CAPEX requirements, though this may change with product development cycles. Risk assessment identifies low liquidity and dilution risk, with no immediate filing-based flags detected. The company's debt-to-equity ratio of 0.03 indicates a conservative capital structure, though the high P/E ratio of 89.25 suggests market expectations of future earnings growth. Recent filings and transcripts show no material events in the last 90 days. The company's 10-K filing from 2023-04-01 details ongoing R&D investments in low-power microcontroller units, but no significant regulatory or operational risks were disclosed.